Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents

N Engl J Med. 2021 Nov 25;385(22):2101-2103. doi: 10.1056/NEJMc2114290. Epub 2021 Oct 20.

Authors

Ben Y Reis¹, Noam Barda², Michael Leshchinsky², Eldad Kepten², Miguel A Hernán³, Marc Lipsitch³, Noa Dagan⁴, Ran D Balicer⁴

Affiliations

¹ Boston Children's Hospital, Boston, MA.
² Clalit Research Institute, Tel Aviv, Israel.
³ Harvard T.H. Chan School of Public Health, Boston, MA.
⁴ Clalit Research Institute, Tel Aviv, Israel [email protected].

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
BNT162 Vaccine*
COVID-19 / prevention & control*
Child
Humans
Israel
SARS-CoV-2*
Vaccine Efficacy / statistics & numerical data*

Substances

BNT162 Vaccine

Supplementary concepts

SARS-CoV-2 variants